What is Cardinal Health?
Pharmaceutical and medical distribution company with $222.6B of FY2025 revenue and enterprise healthcare scale.
- Category
- Pharmaceutical and medical distribution
- Headquarters
- Dublin, OH
- Founded
- 1971
- Employees
- 48,000+
- Total funding
- Public company; no VC funding
- Status
- NYSE: CAH; ~$40B market cap
What is Cardinal Health?
Cardinal Health is a public pharmaceutical and medical distribution company headquartered in Dublin, OH. It reported $222.6B of FY2025 revenue and operates at global enterprise scale.
Cardinal Health operates in pharmaceutical and medical distribution with a portfolio spanning Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company reported $222.6B of FY2025 revenue, employs about 48,000+, and trades as NYSE: CAH. Its customer base is large, regulated, and relationship-driven, with purchasing decisions shaped by clinical outcomes, compliance, reimbursement, operating leverage, and long-term supply reliability.
The company's scale comes from durable demand in healthcare, recurring consumables or services, installed bases, payer or provider relationships, and disciplined capital allocation. Unlike early-stage software companies, Cardinal Health is evaluated through revenue growth, margins, cash flow, reimbursement exposure, procedure or prescription volume, quality, and regulatory execution.
For sellers, Cardinal Health is not a single buying center. The practical map includes procurement, finance, clinical, IT, security, compliance, operations, supply chain, commercial teams, and business-unit executives. Strong pitches connect directly to patient outcomes, cost-to-serve, risk reduction, revenue capture, uptime, or measurable productivity.
What does Cardinal Health offer?
Cardinal Health offers healthcare products and services across Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution.
- Pharmaceutical distribution· Distribution
- Specialty solutions· Specialty
- Medical products distribution· Medical
- At-Home Solutions· Home care
- Nuclear pharmacy· Nuclear
- OptiFreight Logistics· Logistics
- WaveMark inventory management· Technology
How does Cardinal Health make money?
Cardinal Health makes money from pharmaceutical and medical-product distribution, manufacturer services, specialty solutions, logistics, inventory technology, and medical-products manufacturing.
Cardinal Health makes money from pharmaceutical and medical-product distribution, manufacturer services, specialty solutions, logistics, inventory technology, and medical-products manufacturing. In FY2025, that model produced $222.6B of revenue, showing the scale of the installed base, service footprint, payer/provider contracts, or distribution volume behind the business.
Pricing depends on distribution contracts, manufacturer economics, generic sourcing, specialty volume, logistics fees, medical-product margins, and value-added services; it is negotiated at enterprise scale rather than listed publicly. That makes the relevant "pricing tier" for sellers an enterprise contracting motion: account segmentation, compliance review, value analysis, legal terms, security review, reimbursement impact, and multi-year renewal economics.
Growth is driven by a mix of market expansion, procedure or prescription volume, product launches, acquisitions, geographic reach, contract renewals, operational efficiency, and technology adoption. Vendors should expect rigorous procurement, documented ROI, data-security requirements, and evidence that the product can work inside regulated healthcare operations.
Who leads Cardinal Health?
Cardinal Health is led by Jason Hollar, with finance, operations, clinical, technology, and business-unit leaders shaping major enterprise decisions.
- Jason HollarChief Executive OfficerCEO since 2022Leads Cardinal Health's distribution, specialty, and operational improvement strategy.
- Aaron AltChief Financial OfficerCFO since 2022Finance leader for capital allocation and segment performance.
- Debbie WeitzmanCEO, Pharmaceutical and Specialty SolutionsSenior executive leadershipRuns the largest pharmaceutical distribution platform.
- Steve MasonCEO, Global Medical Products and DistributionSenior executive leadershipLeads medical products, distribution, and supply-chain capabilities.
How do you contact Cardinal Health's leadership?
Cardinal Health publishes investor-relations, media, supplier, customer, and compliance channels, but it does not publish verified personal executive emails for the listed leaders. Use the public investor-relations route (investor.relations@cardinalhealth.com) or official contact forms rather than guessed personal addresses.
investor.relations@cardinalhealth.com is a public investor/contact route; personal executive email format not verifiedHow much funding has Cardinal Health raised?
Cardinal Health is a mature public company, not a venture-backed startup. It trades as NYSE: CAH, had an approximate ~$40B market capitalization in June 2026, and funds growth through operating cash flow, debt markets, public equity access, and acquisition capacity.
Cardinal Health's capital history is a public-company story rather than a disclosed venture-round history. The relevant milestones are founding in 1971, public-market access, acquisitions, debt capacity, dividends or buybacks where applicable, and reinvestment in regulated healthcare capabilities.
The company reported $222.6B of FY2025 revenue and operates with the financing tools expected of a large public healthcare company. Capital is directed toward product development, clinical evidence, facilities, inventory, technology, acquisitions, compliance, reimbursement capabilities, and shareholder returns depending on the business model.
Seller signal: Cardinal Health has meaningful buying power, but budget access is tied to risk, ROI, compliance, and executive sponsorship. Vendors should map proposals to cost reduction, growth, care quality, automation, supply resilience, cybersecurity, data quality, or measurable operating improvement.
How did Cardinal Health get here?
Cardinal Health grew through founding, public-market scale, product expansion, acquisitions, and healthcare-market execution.
- 1971Company foundedCardinal begins as a food wholesaler before pivoting to healthcare distribution.
- 1983IPOCardinal Health becomes publicly traded.
- 1994Drug-distribution expansionAcquisitions turn Cardinal into a national healthcare distributor.
- 2015Cordis acquiredCardinal expands medical products.
- 2022Jason Hollar becomes CEOLeadership focuses on distribution resilience and margin recovery.
- 2025$222.6B revenueFiscal 2025 revenue reflects broad distribution scale.
Who are Cardinal Health's competitors?
Cardinal Health competes with companies that overlap in customers, budgets, clinical categories, distribution channels, or healthcare services.
- McKessonLargest U.S. pharmaceutical distributor and oncology/practice-management competitor.
- CencoraPharmaceutical distribution, specialty, and manufacturer-services competitor.
- Owens & MinorMedical distribution and supply-chain competitor.
- Henry ScheinHealthcare products distributor focused on dental and medical office channels.
- MedlinePrivately held medical-products manufacturer and distributor.
Cardinal Health — frequently asked questions
